While literature related to associations between long-term immune recruitment and localization in the untreated preclinical GBM tumor microenvironment is limited, there have been studies suggesting a retained expression of pro-inflammatory cytokines, such as IFN-γ, in CD4+ cells promoting T cell migration into the CNS in GBM 44, 45. The gene discussed is CD4; the disease is glioblastoma.